1/28
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
HFNC Benefits
Precise FiO2 (21%-100%) to improve oxygenation
High flow rates (up to 70 LPM) → alleviate respiratory distress
Optimal heat (37 C) and humidity improves pt comfort/compliance and enhances mucous clearance
HFNC Indications
High O2 requirements
Mild to moderate respiratory distress
Bridge between conventional oxygen therapy and non-invaisive ventilation
Pt uncomfortable/non-compliant with oxygen therapy with mask (associated with a drop in SpO2 below acceptable limits)
HFNC Contraindications
aLOC and/or apneas
Acute respiratory failure (inc PaCO2, dec pH)
Untreated pneumothorax or pneumomedianstinum
Postop abdo sx
Mucosal edema
Airway anomalies
Deviated septum
Settings (HFNC)
Temperature
Flow
FiO2
Temperature Settings (HFNC)
31
34
37
Flow Settings (HFNC)
Rate of gas flow through cannula
Set and titrated based on WOB
Adults between 30-70 L/min
FiO2 Settings (HFNC)
% of O2 delivered to pt
Set and titrated based on SpO2 and PaO2
0.21-1.0 (100%)
Oxygen Titration by Nursing
CAN ONLY TITRATE FiO2!!!
Maximum change of 10%
Must contact RT immediately
Adjust using flow meter
HFNC Assessment Q4 (RN/RT)
SpO2
HR
RR
WOB
Air entry via auscultation
Need for suctioning
Skin integrity
Stable HFNC
FiO2 less than 50%, flow rate stabilized or weaning (ward)
Unstable HFNC
FiO2 50% or greater, flow rate escalating (stepdown or critical care)
Airvo Trach
Heated humidity to trach pt, rate 20-30 L/min (not considered HF)
NIPPV Definition
Assists ventilation by delivering pressurized air. Senses pt respiratory effort by monitoring airflow within the circuit
Goals of NIPPV
Decrease WOB
Improve oxygenation
Reduce/avoid intubations
Promote lung recruitment
Reduce amount of sedation used
Reduced resp muscle fatigue
Decrease incidence of ventilator associated pneumonia
Improve pt mobiliation, communication
Decreased length of ICU stay
Reduce hospital mortality
NIPPV Indications
Ventilation failure (elevated or rising PaCO2, moderate-severe acidosis)
Oxygenation failure
Respiratory muscle weakness/fatigue (neuromusclar disorders)
Acute pulmonary edema
OSA
Chest wall deformitites
Physician ordered scope of treatment (POST)
NIPPV Absolute Contraindications
Respiratory arrest with no spontaneous respiratory effort
Cardiac arrest
Patient refusal
Upper airway obstruction
High risk for aspiration
Inability to protect airway (decreased LOC)
Acute GI bleed
NIPPV Relative Contraindications
Copious secretions
Hemodynamic instability
Emphysema
Sinus/ear infection
Noncompliant pt
NIPPV Possible Complications
Skin breakdown
Decreased CO
Hypotension
Arrhythmias
Gastric distension
N/V
Eye irritation
Tension pneumo
PEEP (Positive End Expiratory Pressure)
Positive pressure maintained in airways at the end of expiration. Used to splint open airways, improve gas exchange, prevent alveolar collapse
Physiological PEEP is 3-5 cmH2O
CPAP
Single pressure level, pt breathes spontaneously from elevated baseline pressure
Set: PEEP or EPAP + FiO2
CPAP Indications
Oxygenation (PaO2) problems
OSA
Atelectasis
Ischemic heart disease
PS/IPAP
IPAP → Inspiratory positive airway pressure (set above 0)
PS → Pressure support (usually set above PEEP)
Positive pressure delivered and maintained during inspiration
Supports pt effort
Max pressure = PS + PEEP
BiPAP
Two pressure levels
Set: PEEP or EPAP + IPAP or PS + FiO2
IPAP vs EPAP
IPAP always set higher than EPAP - Difference determines volume of breath
Larger pressure difference → larger volume
BiPAP Backup
PEEP/EPAP + IPAP/PS + RR + FiO2
If not resp effort detected, will be used to ventilate until intubation
BiPAP Indications
Ventilation (PaCO2) and/or oxygenation (PaO2) problems
Pulmonary edema
COPD
Obesity hypoventilation syndrome
Severe OSA
Central sleep apnea
Neuromuscular disorders
Type 1 NIPPV Patients
Acute NIV need. Unstable, requiring marked clinical improvement (Critical care, stepdown)
Must be awake, oriented, capable of calling for help
Type 2 NIPPV Patients
Require NIV, short term discontinuation does not pose life threatening risk (Location determined by MD/RT/RN)
Type 3 NIPPV Patients
Non-acite, stable. Established NIV treatment, including nocturnal CPAP (Wards)